Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-22
DOI
10.1186/s13046-022-02506-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma
- (2021) Bethany Veo et al. Cell Reports
- Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma
- (2021) Kent A Riemondy et al. NEURO-ONCOLOGY
- Modeling medulloblastoma in vivo and with human cerebellar organoids
- (2020) Claudio Ballabio et al. Nature Communications
- The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective
- (2020) Cristina Casalou et al. Frontiers in Cell and Developmental Biology
- BET Inhibitors Synergize with Carfilzomib to Induce Cell Death in Cancer Cells via Impairing Nrf1 Transcriptional Activity and Exacerbating the Unfolded Protein Response
- (2020) Janakiram R. Vangala et al. Biomolecules
- An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
- (2020) Jamie Zagozewski et al. Nature Communications
- Core transcriptional regulatory circuitries in cancer
- (2020) Ye Chen et al. ONCOGENE
- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- Super-enhancers in cancer
- (2019) Palaniraja Thandapani PHARMACOLOGY & THERAPEUTICS
- A Practical Review of Proteasome Pharmacology
- (2019) Tiffany A. Thibaudeau et al. PHARMACOLOGICAL REVIEWS
- Targeting the Small GTPase Superfamily through their Regulatory Proteins
- (2019) Janine L. Gray et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Glioma Stem Cell Specific Super Enhancer Promotes Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling
- (2019) Ryan C Gimple et al. Cancer Discovery
- Reading, writing and erasing mRNA methylation
- (2019) Sara Zaccara et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
- (2019) Grant L. Lin et al. Science Translational Medicine
- NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
- (2019) Eleni Frisira et al. Cell Death & Disease
- NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma
- (2018) Alexandra Garancher et al. CANCER CELL
- Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma
- (2018) Margaret Stromecki et al. Molecular Oncology
- Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy
- (2018) Guoqing Qian et al. CANCER LETTERS
- Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
- (2018) Adam D. Durbin et al. NATURE GENETICS
- TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
- (2018) Bieke Decaesteker et al. Nature Communications
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Proteasome inhibitors in cancer therapy
- (2017) Elisabet E. Manasanch et al. Nature Reviews Clinical Oncology
- OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma
- (2017) Gaylor Boulay et al. Cancer Discovery
- OTX015 (MK-8628), a novel BET inhibitor, displaysin vitroandin vivoantitumor effects alone and in combination with conventional therapies in glioblastoma models
- (2016) Caroline Berenguer-Daizé et al. INTERNATIONAL JOURNAL OF CANCER
- Active medulloblastoma enhancers reveal subgroup-specific cellular origins
- (2016) Charles Y. Lin et al. NATURE
- Sambamba: fast processing of NGS alignment formats
- (2015) Artem Tarasov et al. BIOINFORMATICS
- Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
- (2015) Kaijun Di et al. NEURO-ONCOLOGY
- BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
- (2015) Anton George Henssen et al. Oncotarget
- Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
- (2015) Sujatha Venataraman et al. Oncotarget
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- (2014) Yujie Tang et al. NATURE MEDICINE
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells
- (2012) R.-Y. Bai et al. CANCER RESEARCH
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells
- (2011) Jens Bunt et al. INTERNATIONAL JOURNAL OF CANCER
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN
- (2008) John H. Chi et al. JOURNAL OF NEUROSURGERY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now